Evidence reviews – September 2023
The following documents contain the evidence that was used to develop the 2023 recommendations:
- Impact of BMI on choice of place of birth
- Initial assessment of women reporting prelabour rupture of membranes
- Sterile water injections
- Remifentanil patient-controlled analgesia
- Programmed intermittent epidural bolus
- Use of oxytocin in the first or second stage of labour
- Position for birth
- Pushing techniques
- Interventions to reduce perineal trauma
- Prophylactic antibiotics for birth with forceps or ventouse
- Active and physiological management of the third stage
- Route of administration of oxytocin in the third stage of labour
- Uterotonics for the prevention of postpartum haemorrhage
- Position of the baby during cord clamping
- Pharmacological management of postpartum haemorrhage
These documents preserve evidence reviews and committee discussions for areas of the guideline before 2023:
Other supporting evidence
This page was last updated: